drug
lanthanum carbonate
Marketedupdated 3mo agoby Barr Laboratories Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(0)
nothing on the calendar yet
Trials studying lanthanum carbonate
- phase4Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders
- phase2A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis
- N/AThe Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 1, 2030
~4.3 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Dec 1, 2030formulationUS 89803274.3y
- Dec 1, 2030formulationUS 89803274.3y
- Dec 1, 2030formulationUS 90233974.3y
- Dec 1, 2030formulationUS 90233974.3y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 53m ago
Found something off?
comments(0)
5-min edit window · permanent after that